Related Experiment Video
Updated: Jun 28, 2026
Myelin Oligodendrocyte Glycoprotein (MOG35-55) Induced Experimental Autoimmune Encephalomyelitis (EAE) in C57BL/6 Mice
Published on: April 15, 2014
[Mouse model of experimental antoimmune encephalomyelitisin C57BL/6J and expression of macrophage migration
Yun-chun Gao1, Yu-zhong Wang, Rui Wang
1Department of Neurology, Xiangya Hospital, Central South University, Changsha 410008, China.
Objective:
To detect the expression of macrophage migration inhibitory factor(MIF) in the brain and spinal cord of chronic non-remitting model of experimental autoimmune encephalomyelitis(EAE) mouse, and to discuss their effect on EAE/MS.
Methods:
Seventy-two female SPF C57BL/6J mice, aged 6k8 weeks, were randomly divided into an EAE group, a blank group, and an adjuvant group. The mice were immuned by mMOG35-55 and CFA. Immunohistochemic technique was used to detect the expression of MIF in the brain and spinal cord.
Results:
In the EAE group, we observed up-regulation of MIF of central nervous system(CNS) at onset, peak and chronic phase. During each phase, the difference of MIF between the EAE group and each of the other 2 groups was significant (P<0.05). In the EAE group, the expression of MIF was the highest at the peak, which was different from other periods (P<0.05).
Conclusion:
MIF significanty expressed during the procedure of EAE disease, and may be related with the onset and exacerbation of EAE.
Insights
Macrophage migration inhibitory factor (MIF) is significantly upregulated in the central nervous system during experimental autoimmune encephalomyelitis (EAE) in mice. This suggests MIF plays a role in the onset and worsening of EAE, a model for multiple sclerosis (MS).
Area of Science:
- Neuroimmunology
- Inflammatory diseases
- Central nervous system research
Context:
- Experimental autoimmune encephalomyelitis (EAE) is a widely used mouse model to study the pathogenesis of multiple sclerosis (MS).
- Understanding the molecular mechanisms underlying EAE progression is crucial for developing effective therapeutic strategies for MS.
- Macrophage migration inhibitory factor (MIF) is a pleiotropic cytokine with known roles in inflammation and immunity.
Purpose:
- To investigate the expression patterns of macrophage migration inhibitory factor (MIF) in the brain and spinal cord of mice with chronic non-remitting experimental autoimmune encephalomyelitis (EAE).
- To explore the potential role of MIF in the development and progression of EAE, offering insights into its relevance for multiple sclerosis (MS).
Summary:
- Immunohistochemistry revealed significant upregulation of MIF in the central nervous system (CNS) of EAE mice during the onset, peak, and chronic phases compared to control groups.
- MIF expression levels were highest during the peak phase of EAE, indicating a temporal correlation with disease severity.
- The study observed significant differences in MIF expression between the EAE group and control groups (blank and adjuvant) across all disease phases (P<0.05).
Impact:
- These findings highlight MIF as a key inflammatory mediator in the pathogenesis of EAE.
- The results suggest that MIF may be a potential therapeutic target for managing EAE and, by extension, multiple sclerosis (MS).
- Further research into MIF's specific mechanisms in EAE could lead to novel treatment strategies for demyelinating diseases.
More Related Videos
05:44Modeling Multiple Sclerosis in the Two Sexes: MOG35-55-Induced Experimental Autoimmune Encephalomyelitis
Published on: October 13, 2023
08:47Induction of Experimental Autoimmune Encephalomyelitis in Mice and Evaluation of the Disease-dependent Distribution of Immune Cells in Various Tissues
Published on: May 8, 2016